Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Burchardt

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
World Journal of Urology|December 3, 2021
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCCSilvia Ribback, Stefan Winter, Tobias Klatte, et al.
International Journal of Oncology|December 10, 2015
Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathwaysHannah Grossebrummel, Tilmann Peter, Robert Mandelkow, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha)Aristotelis G Anastasiadis, Mohamed A Ghafar, Laurent Salomon, et al.
Oncogene|November 7, 2002
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cellsMin-Wei Chen, Francis Vacherot, Alexandre De La Taille, et al.
Journal of Sex & Marital Therapy|April 4, 2002
Sexual dysfunction is common and overlooked in female patients with hypertensionMartin Burchardt, Tatjana Burchardt, Aristotelis G Anastasiadis, et al.
World Journal of Urology|March 17, 2015
Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargementIason Kyriazis, Piotr P Świniarski, Stephan Jutzi, et al.
Urologic Oncology|September 2, 2018
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinomaAndré Steven, Sandra Leisz, Sebastian Fussek, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2022
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinomaNils Kroeger, Cédric Lebacle, Justine Hein, et al.
World Journal of Urology|July 17, 2008
Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experienceRoman Ganzer, Robert Rabenalt, Michael C Truss, et al.
Urologia Internationalis|July 11, 2015
Acceptance, Prevalence and Indications for Robot-Assisted Laparoscopy - Results of a Survey Among Urologists in Germany, Austria and SwitzerlandFlorian Imkamp, Thomas R W Herrmann, Yuri Tolkach, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
World Journal of Urology|December 3, 2021
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCCSilvia Ribback, Stefan Winter, Tobias Klatte, et al.
International Journal of Oncology|December 10, 2015
Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathwaysHannah Grossebrummel, Tilmann Peter, Robert Mandelkow, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha)Aristotelis G Anastasiadis, Mohamed A Ghafar, Laurent Salomon, et al.
Oncogene|November 7, 2002
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cellsMin-Wei Chen, Francis Vacherot, Alexandre De La Taille, et al.
Journal of Sex & Marital Therapy|April 4, 2002
Sexual dysfunction is common and overlooked in female patients with hypertensionMartin Burchardt, Tatjana Burchardt, Aristotelis G Anastasiadis, et al.
World Journal of Urology|March 17, 2015
Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargementIason Kyriazis, Piotr P Świniarski, Stephan Jutzi, et al.
Urologic Oncology|September 2, 2018
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinomaAndré Steven, Sandra Leisz, Sebastian Fussek, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2022
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinomaNils Kroeger, Cédric Lebacle, Justine Hein, et al.
World Journal of Urology|July 17, 2008
Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experienceRoman Ganzer, Robert Rabenalt, Michael C Truss, et al.
Urologia Internationalis|July 11, 2015
Acceptance, Prevalence and Indications for Robot-Assisted Laparoscopy - Results of a Survey Among Urologists in Germany, Austria and SwitzerlandFlorian Imkamp, Thomas R W Herrmann, Yuri Tolkach, et al.
Pageof 11